Advertisement

Incidence, Predictors, and Implications of Access Site Complications With Transfemoral Transcatheter Aortic Valve Implantation

      Our study objective was to assess the incidence, predictors, and implications of access site complications related to transfemoral transcatheter aortic valve implantation (TAVI). We pooled the prospective TAVI databases of 5 experienced centers in Europe enrolling only transfemoral cases for this analysis. Access site complications were defined according to the Valve Academic Research Consortium end-point definitions. The global transfemoral TAVI database contained 986 patients. Percutaneous access and closure was performed in 803 patients (81%) and a surgical strategy in 183 (19%). Incidences of major vascular complications, life-threatening/disabling bleeding, and major bleeding were 14.2%, 11%, and 17.8% respectively. In the patient cohort with a completely percutaneous access strategy, major vascular complications and life-threatening/disabling bleedings were related to closure device failure in 64% and 29%, respectively. Female gender (odds ratio 1.63, 95% confidence interval 1.12 to 2.36) and use of >19Fr system (2.87, 1.68 to 4.91) were independent predictors for major vascular complications. Female gender (odds ratio 2.04, 95% confidence interval 1.31 to 3.17), use of >19Fr system (1.86, 1.02 to 3.38), peripheral arterial disease (2.14, 1.27 to 3.61), learning effect (0.45, 0.27 to 0.73), and percutaneous access strategy (2.39, 1.16 to 4.89) were independently associated with life-threatening/disabling bleedings. In conclusion, transfemoral TAVI is associated with a >10% incidence of major vascular-related complications. A considerable number of these events is related to arteriotomy closure failure. Arterial sheath size and female gender are important determinants of major vascular complications and life-threatening/disabling bleeding.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Piazza N.
        • Grube E.
        • Gerckens U.
        • den Heijer P.
        • Linke A.
        • Luha O.
        • Ramondo A.
        • Ussia G.
        • Wenaweser P.
        • Windecker S.
        • Laborde J.C.
        • de Jaegere P.
        • Serruys P.W.
        Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval.
        EuroIntervention. 2008; 4: 242-249
        • Zahn R.
        • Gerckens U.
        • Grube E.
        • Linke A.
        • Sievert H.
        • Eggebrecht H.
        • Hambrecht R.
        • Sack S.
        • Hauptmann K.E.
        • Richardt G.
        • Figulla H.R.
        • Senges J.
        Transcatheter aortic valve implantation: first results from a multi-centre real-world registry.
        Eur Heart J. 2011; 32: 198-204
        • Eltchaninoff H.
        • Prat A.
        • Gilard M.
        • Leguerrier A.
        • Blanchard D.
        • Fournial G.
        • Iung B.
        • Donzeau-Gouge P.
        • Tribouilloy C.
        • Debrux J.L.
        • Pavie A.
        • Gueret P.
        Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry.
        Eur Heart J. 2011; 32: 191-197
        • Bosmans J.M.
        • Kefer J.
        • De Bruyne B.
        • Herijgers P.
        • Dubois C.
        • Legrand V.
        • Verheye S.
        • Rodrigus I.
        Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
        Interact Cardiovasc Thorac Surg. 2011; 12: 762-767
        • Tamburino C.
        • Capodanno D.
        • Ramondo A.
        • Petronio A.S.
        • Ettori F.
        • Santoro G.
        • Klugmann S.
        • Bedogni F.
        • Maisano F.
        • Marzocchi A.
        • Poli A.
        • Antoniucci D.
        • Napodano M.
        • De Carlo M.
        • Fiorina C.
        • Ussia G.P.
        Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.
        Circulation. 2011; 123: 299-308
        • Rodes-Cabau J.
        • Webb J.G.
        • Cheung A.
        • Ye J.
        • Dumont E.
        • Feindel C.M.
        • Osten M.
        • Natarajan M.K.
        • Velianou J.L.
        • Martucci G.
        • DeVarennes B.
        • Chisholm R.
        • Peterson M.D.
        • Lichtenstein S.V.
        • Nietlispach F.
        • Doyle D.
        • DeLarochelliere R.
        • Teoh K.
        • Chu V.
        • Dancea A.
        • Lachapelle K.
        • Cheema A.
        • Latter D.
        • Horlick E.
        Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience.
        J Am Coll Cardiol. 2010; 55: 1080-1090
        • Leon M.B.
        • Smith C.R.
        • Mack M.
        • Miller D.C.
        • Moses J.W.
        • Svensson L.G.
        • Tuzcu E.M.
        • Webb J.G.
        • Fontana G.P.
        • Makkar R.R.
        • Brown D.L.
        • Block P.C.
        • Guyton R.A.
        • Pichard A.D.
        • Bavaria J.E.
        • Herrmann H.C.
        • Douglas P.S.
        • Petersen J.L.
        • Akin J.J.
        • Anderson W.N.
        • Wang D.
        • Pocock S.
        Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
        N Engl J Med. 2010; 363: 1597-1607
        • Smith C.R.
        • Leon M.B.
        • Mack M.J.
        • Miller D.C.
        • Moses J.W.
        • Svensson L.G.
        • Tuzcu E.M.
        • Webb J.G.
        • Fontana G.P.
        • Makkar R.R.
        • Williams M.
        • Dewey T.
        • Kapadia S.
        • Babaliaros V.
        • Thourani V.H.
        • Corso P.
        • Pichard A.D.
        • Bavaria J.E.
        • Herrmann H.C.
        • Akin J.J.
        • Anderson W.N.
        • Wang D.
        • Pocock S.J.
        Transcatheter versus surgical aortic-valve replacement in high-risk patients.
        N Engl J Med. 2011; 364: 2187-2198
        • Ducrocq G.
        • Francis F.
        • Serfaty J.M.
        • Himbert D.
        • Maury J.M.
        • Pasi N.
        • Marouene S.
        • Provenchere S.
        • Iung B.
        • Castier Y.
        • Leseche G.
        • Vahanian A.
        Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome.
        EuroIntervention. 2010; 5: 666-672
        • Tchetche D.
        • Dumonteil N.
        • Sauguet A.
        • Descoutures F.
        • Luz A.
        • Garcia O.
        • Soula P.
        • Gabiache Y.
        • Fournial G.
        • Marcheix B.
        • Carrie D.
        • Fajadet J.
        Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population.
        EuroIntervention. 2010; 5 (659–565)
        • Van Mieghem N.M.
        • Nuis R.J.
        • Piazza N.
        • Apostolos T.
        • Ligthart J.
        • Schultz C.
        • de Jaegere P.P.
        • Serruys P.W.
        Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System(R): the Rotterdam experience.
        EuroIntervention. 2010; 5: 673-679
        • Leon M.B.
        • Piazza N.
        • Nikolsky E.
        • Blackstone E.H.
        • Cutlip D.E.
        • Kappetein A.P.
        • Krucoff M.W.
        • Mack M.
        • Mehran R.
        • Miller C.
        • Morel M.A.
        • Petersen J.
        • Popma J.J.
        • Takkenberg J.J.
        • Vahanian A.
        • van Es G.A.
        • Vranckx P.
        • Webb J.G.
        • Windecker S.
        • Serruys P.W.
        Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
        Eur Heart J. 2011; 32: 205-217
        • Leon M.B.
        • Piazza N.
        • Nikolsky E.
        • Blackstone E.H.
        • Cutlip D.E.
        • Kappetein A.P.
        • Krucoff M.W.
        • Mack M.M.
        • Miller C.
        • Morel M.
        • Petersen J.P.
        • Takkenberg J.J.M.
        • Vahanian A.
        • van Es G.
        • Vranckx P.
        • Smith C.
        • Webb J.G.
        • Mohr F.
        • Windecker S.
        • Serruys P.W.
        Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
        J Am Coll Cardiol. 2011; 57: 253-269
        • Godino C.
        • Maisano F.
        • Montorfano M.
        • Latib A.
        • Chieffo A.
        • Michev I.
        • Al-Lamee R.
        • Bande M.
        • Mussardo M.
        • Arioli F.
        • Ielasi A.
        • Cioni M.
        • Taramasso M.
        • Arendar I.
        • Grimaldi A.
        • Spagnolo P.
        • Zangrillo A.
        • La Canna G.
        • Alfieri O.
        • Colombo A.
        Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
        JACC Cardiovasc Interv. 2010; 3: 1110-1121
        • Sharp A.S.
        • Michev I.
        • Maisano F.
        • Taramasso M.
        • Godino C.
        • Latib A.
        • Denti P.
        • Dorigo E.
        • Giacomini A.
        • Iaci G.
        • Manca M.
        • Ielasi A.
        • Montorfano M.
        • Alfieri O.
        • Colombo A.
        A new technique for vascular access management in transcatheter aortic valve implantation.
        Catheter Cardiovasc Interv. 2010; 75: 784-793
        • Stahli B.E.
        • Bunzli R.
        • Grunenfelder J.
        • Buhler I.
        • Felix C.
        • Bettex D.
        • Biaggi P.
        • Tanner F.C.
        • Nguyen-Kim D.L.
        • Plass A.
        • Ge H.
        • Falk V.
        • Luscher T.F.
        • Corti R.
        • Maier W.
        • Altwegg L.A.
        Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC).
        J Invasive Cardiol. 2011; 23: 307-312
        • Wenaweser P.
        • Pilgrim T.
        • Roth N.
        • Kadner A.
        • Stortecky S.
        • Kalesan B.
        • Meuli F.
        • Bullesfeld L.
        • Khattab A.A.
        • Huber C.
        • Eberle B.
        • Erdos G.
        • Meier B.
        • Juni P.
        • Carrel T.
        • Windecker S.
        Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes.
        Am Heart J. 2011; 161: 1114-1124
        • Hayashida K.
        • Lefevre T.
        • Chevalier B.
        • Hovasse T.
        • Romano M.
        • Garot P.
        • Mylotte D.
        • Uribe J.
        • Farge A.
        • Donzeau-Gouge P.
        • Bouvier E.
        • Cormier B.
        • Morice M.C.
        Transfemoral aortic valve implantation new criteria to predict vascular complications.
        JACC Cardiovasc Interv. 2011; 4: 851-858
        • Gurvitch R.
        • Toggweiler S.
        • Willson A.B.
        • Wijesinghe N.
        • Cheung A.
        • Wood D.A.
        • Ye J.
        • Webb J.G.
        Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines.
        EuroIntervention. 2011; 7: 41-48
        • Nuis R.J.
        • Piazza N.
        • Van Mieghem N.M.
        • Otten A.M.
        • Tzikas A.
        • Schultz C.J.
        • van der Boon R.
        • van Geuns R.J.
        • van Domburg R.T.
        • Koudstaal P.J.
        • Kappetein A.P.
        • Serruys P.W.
        • de Jaegere P.P.
        In-hospital complications after transcatheter aortic valve implantation revisited according to the Valve Academic Research Consortium definitions.
        Catheter Cardiovasc Interv. 2011; 78: 457-467
        • Ahmed B.
        • Piper W.D.
        • Malenka D.
        • VerLee P.
        • Robb J.
        • Ryan T.
        • Herne M.
        • Phillips W.
        • Dauerman H.L.
        Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry.
        Circ Cardiovasc Interv. 2009; 2: 423-429
        • Piper W.D.
        • Malenka D.J.
        • Ryan Jr, T.J.
        • Shubrooks Jr, S.J.
        • O'Connor G.T.
        • Robb J.F.
        • Farrell K.L.
        • Corliss M.S.
        • Hearne M.J.
        • Kellett Jr, M.A.
        • Watkins M.W.
        • Bradley W.A.
        • Hettleman B.D.
        • Silver T.M.
        • McGrath P.D.
        • O'Mears J.R.
        • Wennberg D.E.
        Predicting vascular complications in percutaneous coronary interventions.
        Am Heart J. 2003; 145: 1022-1029
        • Peterson E.D.
        • Lansky A.J.
        • Kramer J.
        • Anstrom K.
        • Lanzilotta M.J.
        Effect of gender on the outcomes of contemporary percutaneous coronary intervention.
        Am J Cardiol. 2001; 88: 359-364
        • Argulian E.
        • Patel A.D.
        • Abramson J.L.
        • Kulkarni A.
        • Champney K.
        • Palmer S.
        • Weintraub W.
        • Wenger N.K.
        • Vaccarino V.
        Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions.
        Am J Cardiol. 2006; 98: 48-53
        • Buchanan G.L.
        • Chieffo A.
        • Montorfano M.
        • Maisano F.
        • Latib A.
        • Godino C.
        • Cioni M.
        • Gullace M.A.
        • Franco A.
        • Gerli C.
        • Alfieri O.
        • Colombo A.
        The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN and Medtronic CoreValve ReValving System(R) devices: the Milan registry.
        EuroIntervention. 2011; 7: 556-563
        • Mussardo M.
        • Latib A.
        • Chieffo A.
        • Godino C.
        • Ielasi A.
        • Cioni M.
        • Takagi K.
        • Davidavicius G.
        • Montorfano M.
        • Maisano F.
        • Carlino M.
        • Franco A.
        • Covello R.D.
        • Spagnolo P.
        • Grimaldi A.
        • Alfieri O.
        • Colombo A.
        Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
        JACC Cardiovasc Interv. 2011; 4: 743-750
        • Dauerman H.L.
        • Rao S.V.
        • Resnic F.S.
        • Applegate R.J.
        Bleeding avoidance strategies.
        J Am Coll Cardiol. 2011; 58: 1-10
        • Doyle B.J.
        • Ting H.H.
        • Bell M.R.
        • Lennon R.J.
        • Mathew V.
        • Singh M.
        • Holmes D.R.
        • Rihal C.S.
        Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005.
        JACC Cardiovasc Interv. 2008; 1: 202-209
        • Buchler J.R.
        • Ribeiro E.E.
        • Falcao J.L.
        • Martinez E.E.
        • Buchler R.D.
        • Feres F.
        • Maielo J.R.
        • Haddad N.
        • Ramires J.F.
        • Ellis S.G.
        A randomized trial of 5 versus 7 French guiding catheters for transfemoral percutaneous coronary stent implantation.
        J Interv Cardiol. 2008; 21: 50-55
        • Wenaweser P.
        • Windecker S.
        Anatomical suitability for transcatheter aortic valve implantation with complementary roles for 2 rivals.
        JACC Cardiovasc Interv. 2011; 3: 867-869